166 related articles for article (PubMed ID: 17728905)
21. [Aripiprazole and Tourette syndrome].
Hounie A; De Mathis A; Sampaio AS; Mercadante MT
Braz J Psychiatry; 2004 Sep; 26(3):213. PubMed ID: 15645072
[No Abstract] [Full Text] [Related]
22. Aripiprazole is effective in the treatment of Tourette's disorder.
Constant EL; Borras L; Seghers A
Int J Neuropsychopharmacol; 2006 Dec; 9(6):773-4. PubMed ID: 16734937
[No Abstract] [Full Text] [Related]
23. Effectiveness of a clozapine-aripiprazole combination in Tourette syndrome and bipolar spectrum disorder.
Piccinni A; Veltri A; Marazziti D; Moroni I; Dell'Osso L
J Neuropsychiatry Clin Neurosci; 2013; 25(1):E45. PubMed ID: 23487230
[No Abstract] [Full Text] [Related]
24. Aripiprazole: a treatment for severe coprolalia in "refractory" Gilles de la Tourette syndrome.
Ben Djebara M; Worbe Y; Schüpbach M; Hartmann A
Mov Disord; 2008 Feb; 23(3):438-40. PubMed ID: 18067182
[TBL] [Abstract][Full Text] [Related]
25. Treatment practices in Tourette syndrome: the European perspective.
Rickards H; Cavanna AE; Worrall R
Eur J Paediatr Neurol; 2012 Jul; 16(4):361-4. PubMed ID: 22178398
[TBL] [Abstract][Full Text] [Related]
26. Reinforcement learning and Gilles de la Tourette syndrome: dissociation of clinical phenotypes and pharmacological treatments.
Worbe Y; Palminteri S; Hartmann A; Vidailhet M; Lehéricy S; Pessiglione M
Arch Gen Psychiatry; 2011 Dec; 68(12):1257-66. PubMed ID: 22147843
[TBL] [Abstract][Full Text] [Related]
27. Metabolic effects of aripiprazole and pimozide in children with Tourette syndrome.
Rizzo R; Eddy CM; Calí P; Gulisano M; Cavanna AE
Pediatr Neurol; 2012 Dec; 47(6):419-22. PubMed ID: 23127261
[TBL] [Abstract][Full Text] [Related]
28. Aripiprazole in a patient vulnerable to side effects.
Dehning S; Riedel M; Müller N
Am J Psychiatry; 2005 Mar; 162(3):625. PubMed ID: 15741488
[No Abstract] [Full Text] [Related]
29. Pharmacological treatment of Gilles de la Tourette syndrome.
Hartmann A; Worbe Y
Neurosci Biobehav Rev; 2013 Jul; 37(6):1157-61. PubMed ID: 23137552
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome.
Gulisano M; Calì PV; Cavanna AE; Eddy C; Rickards H; Rizzo R
Neurol Sci; 2011 Dec; 32(6):1213-7. PubMed ID: 21732066
[TBL] [Abstract][Full Text] [Related]
31. A case of late-onset Tourette's disorder successfully treated with aripiprazole: view from blood levels of catecholamine metabolites and brain-derived neurotrophic factor (BDNF).
Ikenouchi-Sugita A; Yoshimura R; Hayashi K; Ueda N; Umene-Nakano W; Hori H; Nakamura J
World J Biol Psychiatry; 2009; 10(4 Pt 3):977-80. PubMed ID: 19225990
[TBL] [Abstract][Full Text] [Related]
32. Aripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: an open-label study of 15 patients.
Glick ID; Poyurovsky M; Ivanova O; Koran LM
J Clin Psychiatry; 2008 Dec; 69(12):1856-9. PubMed ID: 19026264
[TBL] [Abstract][Full Text] [Related]
33. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
Swainston Harrison T; Perry CM
Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
[TBL] [Abstract][Full Text] [Related]
34. Aripiprazole in a case presenting with tourette syndrome and obsessive-compulsive disorder.
Winter C; Heinz A; Kupsch A; Ströhle A
J Clin Psychopharmacol; 2008 Aug; 28(4):452-4. PubMed ID: 18626274
[No Abstract] [Full Text] [Related]
35. Clinical effectiveness of aripiprazole in short-term treatment of tic disorder in children and adolescents: a naturalistic study.
Ho CS; Chiu NC; Tseng CF; Huang YL
Pediatr Neonatol; 2014 Feb; 55(1):48-52. PubMed ID: 23920131
[TBL] [Abstract][Full Text] [Related]
36. Oculogyric crisis: a rare extrapyramidal side effect in the treatment of Tourette syndrome.
Rizzo R; Gulisano M; Calì PV
Eur Child Adolesc Psychiatry; 2012 Oct; 21(10):591-2. PubMed ID: 22692815
[No Abstract] [Full Text] [Related]
37. [Aripiprazole use in children and adolescent psychiatric patients].
Chevreuil C; Polard E; Lemonnier E; Guillemot P; Bentué-Ferrer D;
Therapie; 2011; 66(2):123-30. PubMed ID: 21635859
[TBL] [Abstract][Full Text] [Related]
38. The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients.
Connor KM; Payne VM; Gadde KM; Zhang W; Davidson JR
J Clin Psychiatry; 2005 Jan; 66(1):49-51. PubMed ID: 15669888
[TBL] [Abstract][Full Text] [Related]
39. [Clinical potentialities and perspectives for the use of aripiprazole in other disorders than its classical indications. A critical analysis of the recent literature].
Crocq MA; Camus V; Millet B; Gliskman J; Azorin JM; Krebs MO; Limosin F; Costentin J; Daléry J
Encephale; 2008 Apr; 34(2):187-93. PubMed ID: 18597728
[TBL] [Abstract][Full Text] [Related]
40. Aripiprazole in depersonalization disorder comorbid with major depression and obsessive-compulsive disorder: 3 cases.
Uguz F; Sahingoz M
Clin Neuropharmacol; 2014; 37(4):125-7. PubMed ID: 24992087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
